JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Egle, J. L.
Right arrow Articles by Little, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Egle, J. L., Jr.
Right arrow Articles by Little, J. M.
Journal of Pharmacology And Experimental Therapeutics, Vol. 158, Issue 3, 399-404, 1967
Copyright © 1967 by American Society for Pharmacology and Experimental Therapeutics


THE EFFECT OF DICHLOROISOPROTERENOL, PRONETHALOL AND PROPRANOLOL ON OXYGEN CONSUMPTION IN THE RAT

John L. Egle Jr. 1, Jesse H. Meredith 1, and J. Maxwell Little 1

1 Departments of Pharmacology and Surgery, The Bowman Gray School of Medicine of Wake Forest University, Winston-Salem, North Carolina

Certain beta-adrenergic blocking agents have been observed to increase the oxygen consumption of anesthetized dogs and to increase plasma free fatty acid levels. In this study, the effects of three beta-blocking drugs, dichloroisoproterenol (DCI), pronethalol and propranolol, on total-body oxygen consumption in the rat were examined. Both DCI and pronethalol were found to increase oxygen consumption in a doserelated manner. Propranolol did not increase oxygen consumption but instead lowered it in high doses. Propranolol was found to produce a partial antagonism of the oxygen consumption effects of DCI and pronethalol. Propranolol also afforded protection against lethal doses of DCI and pronethalol. It appears that DCI and pronethalol exert a beta-stimulatory action resulting in increased oxygen consumption. However, propranolol is antagonistic in regard to this response.

Submitted on May 12, 1967
Accepted on July 26, 1967







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1967 by the American Society for Pharmacology and Experimental Therapeutics.